Ouabain-like factor quantification in mammalian tissues and plasma: Comparison of two independent assays

Hypertension

Volumn 30, Issue 4, 1997, Pages 886-896

  Ferrandi, Mara ^a   Manunta, Paolo ^b   Balzan, Silvana ^c   Hamlyn, John M ^d   Bianchi, Giuseppe ^b   Ferrari, Patrizia ^a  

^a Prassis Sigma Tau Research Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Human; Na+,K+ ATPase; Ouabain; Plasma; Rats; Tissue

Indexed keywords

DIGITALIS LIKE FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RADIOENZYMATIC ASSAY; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE DISTRIBUTION;

EID: 0030828005     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.886     Document Type: Article

References (38)

1. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci. 1976;19:935-948.
2. Blaustein MP. Sodium ions, calcium ions, and blood pressure regulation: a reassessment and a hypothesis. Am J Physiol. 1977;232: C165-C173.
3. de Wardener HE, MaeGregor GA. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int. 1980;18:1-9.
4. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews W, Ludens J. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991;88:6259-6263.
5. Hamlyn JM, Ringel R, Schaffer J, Levinson PD, Hamilton BP, Kowarski AA, Blaustein MP. A circulating inhibitor of the Na-K ATPase associated with essential hypertension. Nature Lond. 1982; 300:650-652.
6. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, Ludens JH. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension. 1991;17:930-935.
7. Tymiak AA, Norman JA, Bolgar M, Di Donato GC, Lee H, Parker WL, Lo LC, Berova N, Nakanishi K, Haber E, Haupert GT. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A. 1993;90:8189-8193.
8. Zhao N, Lo LC, Berova N, Nakanishi K, Tymiak A, Ludens JH, Haupert GT. Na-K ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry. 1995;34:9893-9896.
9. Lewis LK, Yandle TG, Lewis JG, Richards AM, Pidgeon GB, Kaaja RJ, Nicholls MG. Ouabain is not detectable in human plasma. Hypertension. 1994;24:549-555.
10. Gomez-Sanchez EP, Foecking MF, Sellers D, Blankenship MS, Gomez-Sanchez CE. Is the circulating ouabain-like compound ouabain? Am J Hypertens. 1994;7:647-650.
11. Kelly RA, Smith TW. Is ouabain the endogenous digitalis? Circulation. 1992;86:694-697.
12. Nicholls MG, Richards AM, Lewis LK, Yandle TG. Ouabain: a new steroid hormone? Lancet. 1995;346:1381-1382.
13. Hansen O. Do putative endogenous digitalis-like factors have a physiological role? Hypertension. 1994;24:640-642.
14. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, Du Charme DW. Development of an immunoassay for endogenous digitalis-like factor. Hypertension. 1991;17:936-943.
15. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994;12:549-560.
16. Barber BR, Ferrari P, Bianchi G. The Milan hypertensive strain: a description of the model. In: Ganten D, de Jong W, eds. Handbook of Hypertension. Amsterdam, Netherlands: Elsevier; 1994:316-345.
17. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P. Ouabainlike factor in Milan hypertensive rats. Am J Physiol. 1992; 263:F739-F748.
18. Ferrandi M, Minotti E, Florio M, Bianchi G, Ferrari P. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats. J Hypertens. 1995; 13:1571-1574.
19. Di Bartolo V, Balzan S, Pieraccini L, Ghione S, Pegoraro S, Biver P, Revoltella R, Montali U. Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC. Life Sci. 1995;57:1417-1425.
20. Haupert GT, Carilli CT, Cantley LC. Hypothalamic sodium transport inhibitor is a high affinity reversible inhibitor of Na-K ATPase. Am J Physiol. 1984;247:F919-F924.
21. Jorgensen PL. Purification and characterization of the Na-K ATPase from outer medulla of mammalian kidney. Biochim Biophys Acta. 1974;356:36-52.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
23. Doris PA, Jenkins LA, Stocco DM. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension. 1994;23:632-638.
24. Bova S, Blaustein MP, Ludens JH, Harris DW, DuCharme DW, Hamlyn JM. Effects of an endogenous ouabainlike compound on heart and aorta. Hypertension. 1991;17:944-450.
25. Leenen FH, Harmse E, Yu H, Ou C. Effects of dietary sodium on central and peripheral ouabainlike activity in spontaneously hypertensive rats. Am J Physiol. 1993;264:H2051-H2055.
26. Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM. Endogenous marinobufagenin-like immunoreactive substance: a possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens. 1996;9: 982-990.
27. Doris PA. Ouabain in plasma from spontaneously hypertensive rats. Am J Physiol. 1994;266(Heart Circ Physiol 35):H360-H364.
28. Hout SJ, Pumnani MB, Clough DL, Buggy J, Bryant HJ, Harder DR, Haddy FJ. Sodium-potassium pump activity in reduced renal mass hypertension. Hypertension. 1983;5(part 2):I-94-I-100.
29. Worgall S. Hänze J, Wagner R, Peiser C, Lang RE, Sulyok E, Rascher W, Characterization of ouabain-like immunoreactivity in human urine. J Hypertens. 1996;14:623-628.
30. Rossi GP, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995;13: 1181-1191.
31. Goto A, Yamada K, Hazama H, Uehara Y, Atarashi K, Hirata Y, Kimura K, Omata M. Ouabainlike compound in hypertension associated with ectopic corticotropin syndrome. Hypertension. 1996;28: 421-425.
32. Bagrov A, Fedorova O, Roukoyatkina N, Zhabko E. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na-K pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats. Cardiovasc Res. 1993;27:1045-1050.
33. Dong JG, Akritopoulou-Zanze I, Guo J, Berova N, Nakanishi K, Hauper GT. Cd theorical studies on ouabain pentanaphthoate analogs. In: Beaugé LA, Garrahan PJ, Gadsby DC, eds. Proceedings of the VIIIth International Conference on the Na/K-ATPase and Related Transport ATPases. Ann N Y Acad Sci. In press.
34. Hamilton BP, Manunta P, Laredo J, Hamilton JH, Hamlyn JM. The new adrenal steroid hormone ouabain. Curr Opin Endocrinol Diabetes. 1994;123-131.
35. Naruse K, Naruse M, Tanabe A, Yoshimoto T, Watanabe Y, Kurimoto F, Horiba N, Tamura M, Inagami T, Demura H. Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension. 1994;23(suppl 1):I-102-I-105.
36. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology. 1994;135:794-797.
37. Leenen FHH, Harmsen E, Yu H, Ou C. Effects of dietary sodium on central and peripheral ouabainlike activity in spontaneously hypertensive rats. Am J Physiol. 1993;264(Heart Circ Physiol 33): H2051-H2055.
38. Leenen FHH, Harmsen E, Yu H. Dietary sodium and central vs peripheral ouabain-like activity in Dahl salt-sensitive vs salt resistant rats. Am J Physiol. 1994;267:H1916-H1920.